Clinical Trials Directory

Trials / Unknown

UnknownNCT04248309

Serum Progesterone Level in HRT-FET:a RCT

The Effect of Serum Progesterone Level on Day 3 in HRT-FET Cycles on the Clnical Outcome: a Randomized Controlled Study

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
423 (estimated)
Sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Academic / Other
Sex
Female
Age
20 Years – 41 Years
Healthy volunteers
Not accepted

Summary

In the window of implantation, progesterone plays an important role. Sufficient serum progesterone is basic for ongoing pregnancy. Vaginal progesterone is more and more widely used in ART. As it has no hepatic first pass effect. What is the optimal serum level for pregnancy when use vaginal progesterone is not known yet? Hormone replacement therapy- FET is the optimal strategy to explore this question. There are some retrospective studies showed that the serum progesterone level on embryo transfer day (D3 or D5) or pregnancy test day (D14) lower than 10-11ng/ml is significantly associated with ongoing pregnancy rate in HRT-FET cycles. This prospective study is designed to compare the ongoing pregnancy rate between different serum progesterone levels on D3 and to explore the intervention of additional progesterone supplement since D3 is helpful in HRT-FET cycles.

Conditions

Interventions

TypeNameDescription
DRUGintramuscular progesterone 20-40mg from D3 until pregnancy testserum progesterone \<7.24ug/L, followed by randomized A1: plus additional treatment(intramuscular progesterone 20-40mg from D3 )

Timeline

Start date
2020-03-01
Primary completion
2021-03-01
Completion
2021-04-01
First posted
2020-01-30
Last updated
2020-01-30

Source: ClinicalTrials.gov record NCT04248309. Inclusion in this directory is not an endorsement.